340B Drug Discount Program

CHA Responds to Senate Request for Information on 340B Program

CHA submitted comments in response to a bipartisan request from six U.S. senators seeking information on the 340B Drug Pricing Program. In the letter, CHA shared information to underscore the importance of the 340B program in maintaining access to health care for individuals who live in rural and underserved communities.  

CHA Issues Summary of Proposed Remedy for Prior 340B Payment Cuts

CHA has issued a members-only summary, prepared by Health Policy Alternatives, Inc., of the proposed remedy issued by the Centers for Medicare & Medicaid Services (CMS) for its 340B-acquired drug payment policy that was in effect from 2018-2022 for hospitals paid under the outpatient prospective payment system. The proposal is in response to a remand from the U.S. District Court for the District of Columbia and the U.S. Supreme Court’s decision in American Hospital Association v. Becerra

U.S House Holds Multiple Hearings on Hospital Issues

CHA thanks members for responding to the targeted alert calling for hospitals to contact their congressional representatives ahead of the four House subcommittee hearings on transparency, disproportionate share hospital (DSH) payments, outpatient payments, 340B, physician-owned hospitals, tax-exempt status, and many other hospital issues.